The Longest Day: Understanding Alzheimer's Disease and the Ongoing Fight for a Cure

Strategic Insights -

Alzheimer's disease affects millions worldwide, causing devastating symptoms and a loss of personal autonomy. The Alzheimer's Association's The Longest Day fundraising initiative highlights the importance of awareness and research, particularly during June's National Alzheimer's and Brain Awareness Month. This year's summer solstice, marking the longest day of the year, serves as a poignant reminder of the daily struggles faced by those affected by Alzheimer's. The initiative encourages individuals to participate in their favorite activities, raising funds for research and support.

Key Takeaways:

  • The Alzheimer's Association's The Longest Day fundraising initiative runs throughout June, with the goal of raising awareness and funds for Alzheimer's research.
  • The initiative was created to symbolize how, for those affected by Alzheimer's, every day can feel like "the longest day."
  • Participants in The Longest Day typically engage in an activity they love, honoring a caregiver, someone living with Alzheimer's, or someone lost to the disease.
  • The Alzheimer's Association has provided a range of research fundraising ideas, including organizing group runs, pickleball tournaments, bowling parties, cookouts, and book clubs.
  • A recent FDA approval of a blood test for Alzheimer's disease marked an important step in diagnosis, detecting amyloid plaques through a blood draw.
  • Early symptoms of Alzheimer's disease include sudden changes in mood or personality, difficulty completing familiar tasks, and trouble understanding written or spoken words.
  • Blood testing can be an important component of the diagnostic process, but currently, physicians use a combination of neurological exams, cognitive assessments, brain imaging, and spinal fluid analysis to determine if a patient is suffering from Alzheimer's.
  • Nearly 4 in 5 Americans would want to know if they had Alzheimer's disease before it impacted their lives, highlighting the importance of advancing toward diagnostic testing that is simple to administer and widely available.
  • Remaining 90% of Americans would prefer a simple, blood-based biomarker screening for early diagnosis.

Statistics:

  • Alzheimer's disease is a progressive and invariably fatal form of dementia.
  • The Alzheimer's Association spends all of June promoting The Longest Day fundraising initiative.
  • The summer solstice, marking the longest day of the year, can occur between June 20 and June 22.
  • The recent FDA approval of a blood test for Alzheimer's disease detected amyloid plaques through a blood draw.
  • Blood-based biomarkers are reshaping the identification and understanding of Alzheimer's disease.
  • Early symptoms of Alzheimer's disease affect nearly 90% of Americans, with mood/personality changes being a key indicator.

Sources:

  • National Weather Service (no date)
  • Alzheimer's Association (no date)
  • U.S. Food and Drug Administration (FDA) (no date)
  • Palm Beach Post (no date)
  • USA TODAY NETWORK (no date)
  • alz.org (no date)